Paion AG
XETRA:PA8
Paion AG
Operating Income
Paion AG
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Paion AG
XETRA:PA8
|
Operating Income
€1.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
Operating Income
€908m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
Operating Income
-€232.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
Immatics NV
NASDAQ:IMTX
|
Operating Income
-€101.7m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Operating Income
€120.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
57%
|
CAGR 10-Years
8%
|
|
Formycon AG
XETRA:FYB
|
Operating Income
-€17.7m
|
CAGR 3-Years
-100%
|
CAGR 5-Years
-64%
|
CAGR 10-Years
N/A
|
See Also
What is Paion AG's Operating Income?
Operating Income
1.5m
EUR
Based on the financial report for Dec 31, 2022, Paion AG's Operating Income amounts to 1.5m EUR.